While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a session she recently presented at ADCES21, on the use of SGLT-2 inhibitors in patients with heart failure.
New guidelines on the management of acute and chronic heart failure have been published by the European Society of Cardiology.
It is the first sodium-glucose co-transporter 2 inhibitor to be approved to treat adults with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction.
Case In Point
An 84-year-old man was admitted from the nephrology clinic with worsening renal dysfunction and progressive dyspnea.